From Molecule to Market: How Agentic AI Is Transforming the Pharma Value Chain
The pharma value chain has always been complex, with long development cycles, fragmented data across functions, and decisions that carry enormous scientific and commercial stakes. AI promised to change this. But the path from promise to production has been blocked by the same foundational problem: data that is not unified, trusted, or AI-ready.
Join us for this webinar to examine how to effectively address this challenge. We’ll explore first-hand lessons on building an enterprise AI foundation that creates a single source of truth across R&D, supply chain, and commercial functions.
Attend to learn about:
The architecture decisions required to establish a trusted enterprise data foundation
Real-world AI use cases moving from experimentation into production
Measurable business outcomes across the molecule-to-market journey
How enterprise data foundations can support agentic AI workflows
The potential for AI systems to advance biomarker discovery, dynamically rebalance supply networks, and orchestrate more personalized commercial engagement